Close Menu
    Trending
    • Top CBSE 2025 Results Put GD Goenka Public School Lucknow in the Spotlight Again
    • Sapphire Media Acquires Radio BIG 92.7 FM, Marks a Crucial Milestone for Indian Radio Industry
    • ‘Sugamya Delhi Abhiyan’ Launched to Make Delhi Accessible and Inclusive for Persons with Disabilities
    • Culturist Sundeep Bhutoria to attend historic Cannes screening of restored Satyajit Ray classic
    • Narayana’s Commitment to Academic Excellence Reflected in CBSE 2025 Results
    • Dhruv Consultancy Services Achieves Strong 360% Cons. Net Profit Growth in Q4 FY25
    • Intense Technologies Powers Ahead with 32 Percent Growth in Revenue YoY
    • Let’s Shawarma: Young Entrepreneur Omkar Jadhav’s Journey to Building the Biggest Shawarma Brand in India
    Republic News TodayRepublic News Today
    • Business
    • Entertainment
    • Education
    • Health
    • Lifestyle
    • National
    • World
    • Press Release
    Republic News TodayRepublic News Today
    Home»Health»Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD
    Health

    Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

    By December 16, 2022No Comments2 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

    New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

    Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

    Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

    If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

    Healthcare
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleWhat Makes Honey the Most Natural Superfood and What Are Its Benefits?
    Next Article Gali Guleiyan: In the Shadows with Manoj Bajpai

    Related Posts

    Dr. Sarita Sukhija Presents: The Art of Vaginal Tightening – A Guide by the Guiding Light Behind Myra IVF

    May 14, 2025

    Unlocking the Future of Cancer Care: The Role of NGS and Molecular Biology

    May 14, 2025

    Navneet Bhutani: Championing Women’s Upliftment and Affordable Healthcare

    May 13, 2025
    Recent Posts
    • Top CBSE 2025 Results Put GD Goenka Public School Lucknow in the Spotlight Again
    • Sapphire Media Acquires Radio BIG 92.7 FM, Marks a Crucial Milestone for Indian Radio Industry
    • ‘Sugamya Delhi Abhiyan’ Launched to Make Delhi Accessible and Inclusive for Persons with Disabilities
    • Culturist Sundeep Bhutoria to attend historic Cannes screening of restored Satyajit Ray classic
    • Narayana’s Commitment to Academic Excellence Reflected in CBSE 2025 Results
    • Dhruv Consultancy Services Achieves Strong 360% Cons. Net Profit Growth in Q4 FY25
    • Intense Technologies Powers Ahead with 32 Percent Growth in Revenue YoY
    • Let’s Shawarma: Young Entrepreneur Omkar Jadhav’s Journey to Building the Biggest Shawarma Brand in India
    • EassyLife Honoured as ‘Best Brand of the Year in E-commerce – Services’ by CNBC TV18
    • FlexiBees Launches Job Marketplace to Help Global Firms Hire AI-Vetted Remote Talent in Just 2 Days

    Type above and press Enter to search. Press Esc to cancel.